{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:51:23Z","timestamp":1648576283047},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s12664-010-0012-5","type":"journal-article","created":{"date-parts":[[2010,4,5]],"date-time":"2010-04-05T10:22:04Z","timestamp":1270462924000},"page":"124-125","source":"Crossref","is-referenced-by-count":2,"title":["Nephrotic syndrome with pegylated interferon alfa 2a and ribavirin for a patient with chronic hepatitis C"],"prefix":"10.1007","volume":"29","author":[{"given":"Ajit","family":"Sood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana","family":"Midha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaswinder S.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasham","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,29]]},"reference":[{"key":"12_CR1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0272-6386(03)00828-X","volume":"42","author":"CM Meyers","year":"2003","unstructured":"Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis. 2003;42:631\u201357.","journal-title":"Am J Kidney Dis"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004836-200207000-00019","volume":"35","author":"RA Willson","year":"2002","unstructured":"Willson RA. Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C. J Clin Gastoenterol. 2002;35:89\u201392.","journal-title":"J Clin Gastoenterol"},{"key":"12_CR3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1200\/JCO.1986.4.2.234","volume":"4","author":"JR Quesada","year":"1986","unstructured":"Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol. 1986;4:234\u201343.","journal-title":"J Clin Oncol"},{"issue":"8 Suppl","key":"12_CR4","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/1097-0142(19860415)57:8+<1709::AID-CNCR2820571315>3.0.CO;2-F","volume":"57","author":"GJ Jones","year":"1986","unstructured":"Jones GJ, Itri LM. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients. Cancer. 1986;57(8 Suppl):1709\u2013715.","journal-title":"Cancer"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0272-6386(96)90389-3","volume":"28","author":"E Coroneos","year":"1996","unstructured":"Coroneos E, Petrusevska G, Varghese F, Truong LD. Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy. Am J Kidney Dis. 1996;28:888\u201392.","journal-title":"Am J Kidney Dis"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/ajkd.1998.v31.pm9428462","volume":"31","author":"GM Nassar","year":"1998","unstructured":"Nassar GM, Pedro P, Remmers RE, Mohanty LB, Smith W. Reversible renal failure in a patient with the hypereosinophilia syndrome during therapy with alpha interferon. Am J Kidney Dis. 1998;31:121\u20136.","journal-title":"Am J Kidney Dis"},{"key":"12_CR7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1023\/A:1005638913487","volume":"46","author":"DF Stein","year":"2001","unstructured":"Stein DF, Ahmed A, Sunkhara V, Khalbuss W. Collapsing focal segmental glomerulosclerosis with recovery of renal function: an uncommon complication of interferon therapy for hepatitis C. Dig Dis Sci. 2001;46:530\u201335.","journal-title":"Dig Dis Sci"},{"key":"12_CR8","first-page":"262","volume":"26","author":"CT Bremer","year":"2003","unstructured":"Bremer CT, Lastrapes A, Alper Jr AB, Mudad R. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature. Am J Clin Oncol. 2003;26:262\u20134.","journal-title":"Am J Clin Oncol"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1478-3231.2006.01361.x","volume":"26","author":"C Alves Couto","year":"2006","unstructured":"Alves Couto C, Costa Faria L, Dias Ribeiro D, de Paula Farah K, de Melo Couto OF, de Abreu Farrari TC. Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with peglated intereron alpha-2b and ribavirin treatment for hepatitis C. Liver Int. 2006;26:1294\u20137.","journal-title":"Liver Int"},{"key":"12_CR10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11255-007-9241-7","volume":"40","author":"JL Tovar","year":"2008","unstructured":"Tovar JL, Buti M, Segarra A, Majo J, Esteban R. De novo nephrotic syndrome following pegylated interferon alfa 2b\/ ribavirin therapy for chronic hepatitis C infection. Int Urol Nephrol. 2008;40:539\u201341.","journal-title":"Int Urol Nephrol"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-010-0012-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-010-0012-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-010-0012-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T09:47:48Z","timestamp":1559468868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-010-0012-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s12664-010-0012-5","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}